» Articles » PMID: 33760164

MiR-93-5p Promotes Insulin Resistance to Regulate Type 2 Diabetes Progression in HepG2 Cells by Targeting HGF

Overview
Journal Mol Med Rep
Specialty Molecular Biology
Date 2021 Mar 24
PMID 33760164
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Insulin resistance is a common feature of type 2 diabetes mellitus (T2DM). However, the mechanisms underlying insulin resistance are not completely understood. The present study aimed to investigate the effect of microRNA (miR)‑93‑5p on insulin resistance in T2DM cells. Human hepatocellular carcinoma (HCC; HepG2) cells were cultured in medium with high glucose content (30 mM glucose) to establish an insulin‑resistant cell model (IR group). Glucose consumption and glycogen synthesis assays were performed to assess glucose consumption and glycogen synthesis, respectively. By performing immunoprecipitation assays, the abundance of the Met‑insulin receptor complex was detected in HepG2 cells. miR‑93‑5p and hepatocyte growth factor (HGF) mRNA expression levels were measured via reverse transcription‑quantitative PCR, and HGF protein expression levels were measured via western blotting. A dual‑luciferase reporter assay was conducted to investigate the interaction between miR‑93‑5p and HGF. Cell Counting Kit‑8, BrdU and caspase‑3 activity assays were performed to evaluate cell viability, proliferation and apoptosis, respectively, in insulin‑resistant HepG2 cells following transfection with small interfering RNA‑HGF, HGF overexpression vector, miR‑93‑5p mimic or miR‑93‑5p inhibitor. The results demonstrated that miR‑93‑5p expression was significantly increased and HGF expression was significantly decreased in HCC tissues isolated from patients with or without T2DM compared with adjacent healthy tissues isolated from patients without T2DM. Compared with the IR group, miR‑93‑5p overexpression significantly increased cell proliferation, glucose consumption and glycogen synthesis, but significantly inhibited apoptosis in insulin‑resistant HepG2 cells. By contrast, compared with the IR group, HGF overexpression significantly inhibited cell proliferation, glucose consumption and glycogen synthesis, but significantly enhanced cell apoptosis in insulin‑resistant HepG2 cells. Following co‑transfection with HGF overexpression vector and miR‑93‑5p mimic, miR‑93‑5p mimic‑mediated induction of HepG2 cell proliferation, glucose consumption and glycogen synthesis in insulin‑resistant HepG2 cells was inhibited. Collectively, the results of the present study indicated that miR‑93‑5p enhanced insulin resistance to regulate T2DM progression in HepG2 cells by targeting HGF.

Citing Articles

miR-320b, a Future Expected New Biomarker for Type 2 Diabetes Mellitus Induces Dysglycemia by Targeting PTEN.

Wang J, Tao R, Hu H, Gao J, Liu Y, Xia J Int J Endocrinol. 2024; 2024:5540062.

PMID: 39502509 PMC: 11535181. DOI: 10.1155/2024/5540062.


Fetal Brain-Derived Exosomal miRNAs from Maternal Blood: Potential Diagnostic Biomarkers for Fetal Alcohol Spectrum Disorders (FASDs).

Darbinian N, Hampe M, Martirosyan D, Bajwa A, Darbinyan A, Merabova N Int J Mol Sci. 2024; 25(11).

PMID: 38892014 PMC: 11172088. DOI: 10.3390/ijms25115826.


CircRNA-SCAF8 promotes vascular endothelial cell pyroptosis by regulating the miR-93-5p/TXNIP axis.

Wang B, Yu X, Chen T, Qiu C, Lu W, Zheng X Zhejiang Da Xue Xue Bao Yi Xue Ban. 2023; 52(4):473-484.

PMID: 37643981 PMC: 10495250. DOI: 10.3724/zdxbyxb-2023-0091.


Improves Lipid Metabolism Disorder and Insulin Resistance in Type 2 Diabetic Mice.

Xuan W, Ou Y, Chen W, Huang L, Wen C, Huang G Br J Biomed Sci. 2023; 80:10794.

PMID: 37025162 PMC: 10070466. DOI: 10.3389/bjbs.2023.10794.


Experimental Approaches to Diabetes Mellitus.

Yayla M, Binnetoglu D Eurasian J Med. 2023; 54(Suppl1):145-153.

PMID: 36655459 PMC: 11163337. DOI: 10.5152/eurasianjmed.2022.22304.


References
1.
Fafalios A, Ma J, Tan X, Stoops J, Luo J, DeFrances M . A hepatocyte growth factor receptor (Met)-insulin receptor hybrid governs hepatic glucose metabolism. Nat Med. 2011; 17(12):1577-84. PMC: 3233634. DOI: 10.1038/nm.2531. View

2.
Polesel J, Zucchetto A, Montella M, Dal Maso L, Crispo A, La Vecchia C . The impact of obesity and diabetes mellitus on the risk of hepatocellular carcinoma. Ann Oncol. 2008; 20(2):353-7. DOI: 10.1093/annonc/mdn565. View

3.
Darpolor M, Basu S, Worth A, Nelson D, Clarke-Katzenberg R, Glickson J . The aspartate metabolism pathway is differentiable in human hepatocellular carcinoma: transcriptomics and (13) C-isotope based metabolomics. NMR Biomed. 2014; 27(4):381-9. PMC: 3962779. DOI: 10.1002/nbm.3072. View

4.
von Horn C, Minor T . [Modern concepts for the dynamic preservation of the liver and kidneys in the context of transplantation]. Pathologe. 2019; 40(3):292-298. DOI: 10.1007/s00292-019-0595-2. View

5.
Zhu H, Yu X, Zhang G, Shi X, Bilegsaikhan E, Guo H . Comprehensive analysis of long non‑coding RNA‑messenger RNA‑microRNA co‑expression network identifies cell cycle‑related lncRNA in hepatocellular carcinoma. Int J Mol Med. 2019; 44(5):1844-1854. PMC: 6777664. DOI: 10.3892/ijmm.2019.4323. View